Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Oct/15/2020 Oct/16/2020 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Sep/25/2020 Oct/19/2020 0
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Sep/14/2020 Oct/05/2020 0
Bromhexine hydrochloride Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/03/2020 Oct/24/2020 0
Darunavir Potential treatment - theoretical effect Used to treat other disease Antiviral Aug/27/2020 Sep/28/2020 0
Cobicistat Potential treatment - clinical evidence Used to treat other disease Other treatment Aug/27/2020 Sep/28/2020 0
Alpha 1 antitrypsin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/02/2020 Sep/03/2020 0
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jun/23/2020 Sep/03/2020 0
Leronlimab Potential treatment - clinical evidence Used to treat other disease Other treatment May/05/2020 May/06/2020 0
Interferon alpha Recommended by China's NHC Guidelines Used to treat other disease Antiviral May/05/2020 Sep/03/2020 0